Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price traded up 14.1% during trading on Tuesday . The company traded as high as GBX 2.19 ($0.03) and last traded at GBX 2.17 ($0.03). 1,074,848 shares changed hands during mid-day trading, a decline of 33% from the average session volume of 1,601,397 shares. The stock had previously closed at GBX 1.90 ($0.02).
Cizzle Biotechnology Price Performance
The stock has a market cap of £7.29 million, a price-to-earnings ratio of -183.80 and a beta of 0.38. The business’s fifty day simple moving average is GBX 1.79 and its 200 day simple moving average is GBX 1.86.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- What to Know About Investing in Penny Stocks
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- What is the MACD Indicator and How to Use it in Your Trading
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- D-Wave’s Stock Springs Back in the Quantum Computing Race
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
